The relationship established between Leishmania infantum and the vertebrate host can lead to a self-healing infection or to the manifestation of visceral leishmaniasis, a chronic systemic infection associated with high rates of mortality. We hypothesized that regulatory cytokines, such as interleukin-27 (IL-27), play a role in susceptibility to L. infantum infection. IL-27 is a heterodimeric cytokine composed of IL-27p28 and EBi3 subunits which, when combined, bind to IL-27R, leading to STAT-1 and -3 activation, playing a role in the regulation of the immune response. We observed in this work that IL-27 regulates the Th1/Th17 profiles in a mouse model of visceral leishmaniasis (VL) caused by L. infantum. We showed here that the pathogen recognition by endosomal Toll-like receptors triggers a type I interferon (IFN) response, which acts through the type I IFN receptor and interferon regulatory factor 1 to induce IL-27 production by macrophages. Furthermore, IL-27 plays a major regulatory role in vivo, because Ebi3 ؊/؊ mice can efficiently control parasite replication despite reduced levels of IFN-␥ compared to wild-type mice. On the other hand, the absence of Ebi3 leads to exacerbated IL-17A production in the infected organs as well as in a coculture system, suggesting a direct regulatory action of IL-27 during L. infantum infection. As a consequence of exacerbated IL-17A in Ebi3 ؊/؊ mice, a greater neutrophil influx was observed in the target organs, playing a role in parasite control. Thus, this work unveiled the molecular steps of IL-27 production after L. infantum infection and demonstrated its regulatory role in the IL-17A-neutrophil axis.
V
isceral leishmaniasis (VL), or kala-azar, is a systemic chronic disease with high mortality rates if not treated. It is caused by the parasites Leishmania infantum and L. donovani, and it is estimated that 300,000 new cases and 20,000 deaths occur annually (http://www.who.int/mediacentre/factsheets/fs375/en/). After dermal inoculation by the sandfly vector, the parasite disseminates to the liver, spleen, bone marrow, and lymph nodes of susceptible hosts, causing symptoms such as hepatosplenomegaly, lymphadenopathy, anemia, constant fever, and immunosuppression (1) . Even though it is considered one of the six most important parasitic diseases affecting humans, the immunobiology of VL is not completely understood and novel therapeutic approaches are desired.
The immune response against Leishmania spp. is critically mediated by gamma interferon (IFN-␥)-producing Th1 cells, which activate macrophages to produce leishmanicidal compounds, such as nitric oxide (NO) (2) . Together with IFN-␥, the inflammatory cytokine interleukin-17A (IL-17A) also mediates protection against L. infantum (3, 4) . On the other hand, Th2 cytokines are involved in susceptibility to leishmaniasis (2, 5) . Moreover, the regulatory cytokines IL-10, IL-21, and IL-27 are produced in the bone marrow of VL patients, suggesting their association with the disease (6) .
The cytokine IL-27 is a dimer composed of p28 (IL-30) and EBi3, which together bind to the IL-27R receptor, also a dimer of IL-27R␣ and gp130 (7) . It was first demonstrated that EBi3 is produced largely by Epstein-Barr virus-infected B cells, but later studies also reported its production by T cells (8) , antigen-presenting cells (9) , and even keratinocytes (10) . EBi3 can form heterodimeric cytokines when combined with IL-12p35, forming IL-35, or with IL-27p28, forming IL-27. The latter can regulate a variety of T cell-mediated immune responses, such as inhibition of Th2 (11) and Th17 development (12) , induction of the regulatory molecule Tim3 in Th1 cells (13) , and induction of IL-10 secretion by Th1 lymphocytes and CD8 ϩ T cells (14, 15) . The role of IL-27 in Leishmania infection is dependent on the species and/or experimental setting utilized. In the case of cutaneous leishmaniasis (CL), caused by L. major (16) , IL-27 signaling is involved in host resistance, since Il-27ra Ϫ/Ϫ mice present increased amounts of parasites. However, during L. amazonensis infection, IL-27 administration leads to higher parasite replication, both in vitro and in vivo (17) . In the context of VL caused by L. donovani, Ϫ/Ϫ mice present reduced parasite burdens in the spleen and liver (18) . Therefore, the role of IL-27 in the regulation of the immune response can lead to higher parasite replication or to the control of infection. It was recently observed that visceral leishmaniasis patients present high levels of IL-27 in serum, which decreases after successful treatment (19) . Thus, we hypothesized that IL-27 plays a role in the regulation of immune response during L. infantum infection, which could exacerbate the disease in a mouse model of visceral leishmaniasis.
We showed here that IL-27 is a regulatory cytokine that drives host susceptibility to L. infantum infection. Moreover, we described the mechanisms that control IL-27 production by infected cells, as well as its role in the regulation of the IL-17A-neutrophil axis. The identification of the regulatory mechanisms triggered after Leishmania infection can contribute to the development of rational immune interventions, treatment, and prophylaxis for leishmaniasis.
Quantitative PCR (qPCR). mRNA from tissue samples was obtained after extraction with an SV total RNA isolation system kit (Promega, Madison, WI) according to the manufacturer's instructions. SuperScript III reverse transcriptase (Invitrogen) was used to obtain cDNA. SYBR green mix-based real-time quantitative PCR assays were performed using the StepOnePlus real-time PCR system (Applied Biosystems, Singapore, Malaysia). The primers used in reactions are listed in Table S1 in the supplemental material. The mean threshold cycle (C T ) values were used to calculate the expression of the target genes, which were normalized to the housekeeping genes, using the 2 Ϫ⌬⌬CT formula. Flow cytometry. A fragment from the spleen was harvested and triturated to obtain a single-cell suspension, which was then stimulated and stained. For surface analysis, cells were fixed, washed, and stained with fluorochrome-conjugated anti-class II major histocompatibility complex (MHC) (IA/IE), anti-CD11b, and anti-Ly6G (BD Biosciences, San Diego, CA). For cytokine analysis, cells were stimulated with phorbol myristate acetate (PMA) (50 ng/ml) and ionomycin (500 ng/ml) in the presence of the protein transport inhibitor GolgiPlug (BD Biosciences, San Diego, CA) for 4 h at 5% CO 2 and 37°C. Cells then were fixed and permeabilized using a Cytofix/Cytoperm (BD Biosciences, San Diego, CA) kit according to the manufacturer's instructions. Further, cells were stained with the fluorochrome-conjugated antibodies anti-CD3, anti-CD4, anti-IL-17A, and anti-IFN-␥, followed by acquisition with a FACSCanto II (BD Biosciences, San Diego, CA). Data were analyzed using FlowJo software (Tree Star, OR, USA).
Cell sorting. BMDCs were obtained from C57BL/6 and Ebi3 Ϫ/Ϫ mice as described above and were stained with fluorochrome-conjugated antiCD11c and MHC-II (BD Biosciences, San Diego, CA). Highly purified CD11c hi MHC-II ϩ cells were obtained after cell sorting using a FACSAria III (BD Biosciences, San Diego, CA). Cells were plated and either left uninfected or infected with L. infantum (MOI of 5). Lymph nodes from C57BL/6 mice were collected and triturated, and single-cell suspensions were stained with fluorochrome-conjugated anti-CD4, anti-CD44, and anti-CD62L. Naive CD4 ϩ CD62L ϩ CD44 Ϫ cells were sorted using a FACSAria III (BD Biosciences, San Diego, CA) and were added to cultures containing DCs in the presence of 4 ng/ml of anti-CD3 (clone 145-2C11; BioXCell, NH, USA). After 5 days of culture, supernatants were collected to determine cytokine production.
Immunohistochemistry. Liver fragments fixed in formalin were subjected to routine paraffin embedding. Serial 5-m cuts were adhered to silane-coated slides. Antigen recovery was performed using incubation in citrate buffer (pH 6.0) for 15 min at 42°C. Endogenous peroxidase was blocked using 3% H 2 O 2 , and nonspecific reactions were blocked with 1% bovine serum albumin (BSA). The sections were incubated overnight with a monoclonal rat anti-Ly6G antibody (clone 1A8; BioLegend, San Diego, CA, USA), followed by incubation with a biotinylated secondary antibody and avidin-biotin complex (Vector Laboratories, Ontario, Canada). The reaction was detected with diaminobenzidine, and the sections were counterstained with hematoxylin. The stained area corresponding to Ly6G-positive cells was determined in photomicrographs of 20 fields using ImageJ in concert with the immunohistochemistry (IHC) Toolbox plugin.
Neutralization of IL-17 and IFN-␤. To neutralize IL-17A during infection, 20 g of anti-IL-17A (clone 50104; R&D Systems, Minneapolis, MN) or control IgG was administered i.p. on day Ϫ1, day 7, and day 14 of infection. To neutralize IFN-␤ in vitro, monoclonal rat anti-mouse IFN-␤ (clone RMMB-1; PBL Assay Science, NJ) was added to BMDM cultures at a concentration of 5 g/ml.
Statistics. Each variable from data collected in the experiments was submitted to an analysis of normal distribution and homogeneity of variance. Parametric analyses such as Student t test and analysis of variance (ANOVA) were applied to data presented with normal distribution and variance homogeneity, which were shown as means Ϯ standard errors of the means (SEM). The conclusions took into consideration a significance level of 95% (P Ͻ 0.05), and distinct statistical groups are represented by an asterisk.
RESULTS
Endosomal TLRs and type I IFN signaling are required for IL-27 production in L. infantum infection. We first assessed whether IL-27 is produced during L. infantum infection. For this, C57BL/6 mice were intravenously infected with 10 7 axenic stationary-phase promastigotes, and at the 4th and 6th weeks postinfection (wpi), when the hepatosplenomegaly is observed, samples were collected for mRNA and protein analysis. We observed that both Il-27p28 and Ebi3 transcripts were upregulated after infection compared to uninfected controls (Fig. 1A) . Corroborating these data, high levels of the protein IL-27p28 were observed in the spleen and liver of infected mice (Fig. 1B) . To verify if the cytokine could play a biological role, we examined the kinetics of mRNA expression of the IL-27 receptor subunits Il-27ra and gp130, which were upregulated mainly at week 4 after infection (Fig. 1C) , suggesting that L. infantum infection induces both IL-27 production and its receptor's expression. As IL-27 is produced in vivo, we investigated the mechanisms that lead to its production after L. infantum infection. We first observed that both bone marrow-derived macrophages (BMDMs) ( Fig. 2A ) and dendritic cells (BMDCs) (see Fig.   S1 in the supplemental material) were able to produce IL-27 when infected. As macrophages are the major host cell for Leishmania parasites and therefore are a key to studying susceptibility/resistance during this infection, we screened for IL-27 production in Toll-like receptor (TLR)-deficient BMDMs after L. infantum infection. We observed that the signaling pathways through TRIF and MyD88 are crucial for IL-27 induction, since Trif Ϫ/Ϫ and Myd88 Ϫ/Ϫ BMDMs were unable to produce IL-27. Moreover, TLR3 and TLR9 deficiency in infected BMDMs also abrogated IL-27 production, which was not observed in the absence of TLR4 ( Fig. 2A) .
As it was previously described that type I IFN precedes IL-27 secretion by LPS-stimulated BMDCs (24), we evaluated whether this mechanism also existed in L. infantum-infected macrophages. Interestingly, we observed that BMDMs deficient for TLR3 and TLR9, as well as for MyD88 and TRIF adaptor molecules, were not able to produce IFN-␤ after L. infantum infection, indicating their crucial role in this type of cytokine production (Fig. 2B ). To understand the role of type I IFN signaling in the production of IL-27, we added IFN-␤-neutralizing monoclonal antibodies in BMDM cultures, which reduced the IL-27 levels in supernatants compared to those of controls (Fig. 2C ). To further confirm these results, we added recombinant IFN-␤ in cultures of Tlr3 Ϫ/Ϫ and Tlr9 Ϫ/Ϫ BMDMs infected with L. infantum. The addition of IFN-␤ rescued IL-27 production by infected macrophages, bypassing the need for TLR3 and TLR9 signaling (Fig. 2D) . These results were confirmed and extended using Ifnar Ϫ/Ϫ and Irf-1
BMDMs, which are still defective in IL-27 production even when IFN-␤ was added to the cultures (Fig. 2D) . Together, these results demonstrate that the production of IL-27 induced by L. infantum is dependent on TLR3 and TLR9, as well as on the adaptors TRIF and MyD88, which are crucial for IFN-␤ induction. Moreover, IFN-␤ triggers type I IFN receptor (IFNAR) and interferon regulatory factor 1 (IRF1) signaling, leading to IL-27 production in response to L. infantum infection.
IL-27 confers susceptibility to L. infantum infection by inhibiting Th17 cells. To address the role of IL-27 during L. infantum infection, we infected Ebi3
Ϫ/Ϫ and C57BL/6 wild-type mice with 10 7 promastigotes in stationary growth phase and evaluated the parasite titers in the liver and spleen at the 4th and 6th wpi. We observed that Ebi3 Ϫ/Ϫ mice showed significantly reduced parasite numbers during infection in both organs analyzed (Fig. 3A) as well as reduced hepatosplenomegaly, demonstrated by diminished organ weight at the 6th wpi (Fig. 3B) . Therefore, these data clearly indicated that IL-27 plays a major role in host susceptibility to L. infantum and suggest that IL-27 can modulate the levels of other proinflammatory mediators. Once the Th1 response is classically associated with host protection during Leishmania species infection (2), we determined the numbers of CD3 ϩ CD4 ϩ IFN-␥ ϩ cells in the spleen of infected mice. Although more resistant, reduced frequencies of Th1 cells were found in the spleen of Ebi3 Ϫ/Ϫ mice than in infected C57BL/6 mice ( Fig. 4A and B) . Moreover, IFN-␥ production in tissue homogenates was also reduced in the absence of IL-27 ( Fig. 4C ).
To further understand the mechanism that leads to the resistance observed in Ebi3 Ϫ/Ϫ mice, we evaluated the levels of IL-10 and IL-17A after infection, since these cytokines play a role in host resistance to L. infantum infection (4). To address this question, we infected C57BL/6 and Ebi3 Ϫ/Ϫ mice and evaluated the accumulation of cytokines in spleen and liver homogenates at the 4th and 6th wpi by ELISA. The data demonstrated that Ebi3 Ϫ/Ϫ mice produce significantly higher levels of IL-17A than C57BL/6 mice in both spleen and liver (Fig. 5A) . However, IL-10 levels are slightly decreased in Ebi3 Ϫ/Ϫ mice only in the spleen at the 4th wpi (see Fig. S2 in the supplemental material), which could not explain the higher resistance observed in these mice. We also observed higher numbers of IL-17-producing cells in the spleen of Ebi3 Ϫ/Ϫ mice at the 4th wpi, as observed through gating in FSC lo SSC lo and IL-17 ϩ cells (Fig. 5B) . IL-17A production was mediated by antigen-specific spleen cells, since ex vivo restimulation of splenocyte cultures with L. infantum lysate for 48 h led to significant IL-17A accumulation in the supernatants (Fig. 5C) . We also explored the regulatory role of IL-27 using in vitro coculture systems. For this purpose, highly purified CD11c ϩ MHC-II ϩ cells were obtained from in vitro-differentiated BMDCs, infected with L. infantum, and subsequently cocultured with naive T cells in the presence of anti-CD3. After 5 days, the supernatants were collected to determine the levels of IL-17A, which was produced in culture containing Ebi3 Ϫ/Ϫ DCs and T cells but was not observed in cocultures containing wild-type DCs (Fig. 5D ). These findings showed that IL-27 suppresses the development of IL-17-producing cells during L. infantum infection. Collectively, these data demonstrated the complex role of IL-27 in modulating the inflammatory microenvironment in VL.
Blockade of IL-17A abrogates resistance of Ebi3 ؊/؊ mice. Once IL-17A was overproduced in the absence of Ebi3 during L. infantum infection, we investigated the migration of neutrophils to the spleen and liver of infected mice. It was observed that Ebi3 Ϫ/Ϫ mice present a peak in neutrophil migration at the 4th wpi both in the spleen and liver (Fig. 6A and B) . Moreover, higher expression of Cxcl1, the main chemoattractant for neutrophils, was observed in the spleen of Ebi3 Ϫ/Ϫ mice (Fig. 6C) . The IL-17A-neutrophil axis was confirmed through infection of Il-17ra Ϫ/Ϫ mice, which presented a reduction in the frequency of neutrophils in the spleen (Fig. 6D) . Altogether, the results demonstrated that high levels of IL-17A are related to an increased recruitment of neutrophils.
To confirm that the resistance observed in Ebi3 Ϫ/Ϫ mice during L. infantum infection was due to the IL-17A-neutrophil axis, we blockaded this cytokine in vivo with monoclonal anti-IL-17A (20 g; administered at Ϫ1, 7, and 14 days of infection) and determined the parasite burden at the 4th wpi in the spleen. The data showed that IL-17A blockade in Ebi3 Ϫ/Ϫ mice abrogated the previously observed host resistance (Fig. 7A) . Moreover, the neutrophil influx was also mitigated by IL-17A blockade (Fig. 7B) . These data confirm that the inhibition of IL-17A by IL-27 during L. infantum infection leads to host susceptibility through regulating neutrophil influx.
DISCUSSION
The host immune response against intracellular parasites can determine if the individual will develop a benign, self-healing infection or disease. The production of IL-27 has been observed in the serum of patients with VL, which correlated with the severity of the disease (19) . Thus, we hypothesized that IL-27 could mediate susceptibility to VL. In this work, we observed that after L. infantum infection, EBi3, a component of IL-27, suppressed the host inflammatory response, leading to a susceptibility profile. Infected Ebi3 Ϫ/Ϫ mice presented highly reduced parasite burdens in both spleen and liver compared to C57BL/6 WT mice. Moreover, the target organs of infection were downsized in Ebi3 Ϫ/Ϫ mice compared to organs from C57BL/6 mice, demonstrating that control of parasite replication in these mice is accompanied by reduced signs of active disease. Considering that EBi3 also can bind to IL-12p35 and form IL-35 (8), we observed that Il-12p35 transcripts were very scarce in the organ analyzed (data not shown). In contrast, Il-27p28 and Ebi3 were highly expressed at the same time points, ruling out the role of IL-35 in this context. Moreover, both IL-27R subunits are upregulated at critical time points of infection, where the parasite is efficiently controlled in the absence of Ebi3.
Previous reports have described divergent roles of IL-27 during leishmaniasis, which differ depending on the species of the parasite employed. For example, Il-27r Ϫ/Ϫ mice are susceptible to infection with a nonhealing strain of L. major, presenting exacerbated IL-17 with reduced IL-10 production in the ears and lymph nodes (16) . On the other hand, Il-27r Ϫ/Ϫ mice are more resistant to L. donovani infection; however, severe liver lesions mediated by CD4 ϩ T cells producing IFN-␥ and tumor necrosis factor (TNF) (18) were observed in these mice. In our model of L. infantum infection, Ebi3 deficiency is not involved with immunopathology once reduced signs of hepatosplenomegaly were observed, as mentioned above. In general, the regulatory role of IL-27 can be important to prevent tissue damage in organs such as the skin and viscera; however, this action can lead to higher parasite replication.
In this work, we observed that in the absence of IL-27 there is an accumulation of neutrophils in the target organs. Moreover, we observed that the key mediator of neutrophil infiltration in the spleen of infected mice is IL-17, which induces CXCL1 expression, an important neutrophil chemoattractant. Neutrophils can counteract infections by several mechanisms, such as production of cytokines and chemokines that lead to inflammatory cell recruitment as well as release of granules and neutrophil extracellular traps (25) . The involvement of neutrophils in host resistance to Leishmania species parasites seems to be dependent on the host genetic background as well as the Leishmania species considered. During L. major infection, neutrophils that ingest the parasites display apoptotic markers on their surfaces, and those regulatory "eat me" signals lead to dendritic cell acquisition of parasites in an anti-inflammatory context, culminating in L. major replication (26) . However, during infection with L. amazonensis, the presence of neutrophils reduces the amount of IL-10 produced in the skin, favoring parasite control by the host (27) . In L. infantum infection, the depletion of neutrophils by anti-Ly6G monoclonal antibody administration resulted in increased susceptibility to parasite growth (28) . In accordance with this, during infection with L. donovani, antibody-mediated depletion of neutrophils increases parasite replication in the target organs (29, 30) . Collectively, those reports suggest that during visceral leishmaniasis, neutrophils play a protective role.
Regarding the role of IL-17-mediated protection, our group has already observed that this cytokine is involved in host resistance, since Il-17ra Ϫ/Ϫ mice are susceptible to L. infantum infection. IL-17 can also regulate IL-10 production, and it induces nitric oxide (NO) production by infected macrophages when in combination with IFN-␥ (4). In this work, we observed a critical role of IL-17 in the recruitment of neutrophils to infected organs. Curiously, during L. infantum infection of C57BL/6 mice, IL-17 levels are reduced in the infected organs. We observed that negative regulation of IL-17 is mediated by IL-27 production, since Ebi3 absence leads to exacerbated IL-17 secretion. When IL-17 was blocked through antibody administration, the previously resistant Ebi3 Ϫ/Ϫ mice became as susceptible as the C57BL/6 control, demonstrating the ability of IL-27 to directly block IL-17 release. Moreover, neutrophils were also reduced after anti-IL-17 treatment, confirming the role of IL-17 in neutrophil recruitment to infected organs in parallel to induction of NO production by macrophages, as previously shown by our group. The regulatory role of IL-27 on IL-17 response has been demonstrated under autoimmune inflammatory conditions, such as in experimental autoimmune encephalomyelitis (12) as well as in collagen-induced arthritis (31) . Here, we suggest that IL-27 plays a major role as an important regulatory cytokine implicated in infectious disease.
Regarding the role of IL-27 in the regulation of the Th1 response, we observed that although Ebi3 Ϫ/Ϫ mice are more resistant to infection, there is a reduction in the overall production of IFN-␥ in the infected organs. This result demonstrated that other aspects of the inflammatory response, such as IL-17 and neutrophils, can lead to parasite control even in the absence of a strong Th1 response. It was previously observed that Ebi3 Ϫ/Ϫ mice infected with L. major present reduced levels of IFN-␥ in the ear (32) , in accordance with our results. Thus, IFN-␥ is important to control parasite replication but also can lead to tissue damage, as previously observed (18) .
As we observed that IL-27 is a mediator involved in host susceptibility, we investigated the molecular components necessary for IL-27 production in macrophages. We observed that macrophages deficient for TLR3 and TLR9 completely fail to produce IL-27, suggesting that nucleic acids from L. infantum could activate those receptors to trigger the production of regulatory cytokines. Interestingly, we could not observe a redundant role of these receptors in the induction of IL-27, possibly because the absence of any endosomal TLR abrogates sufficient IFN-␤ production to trigger further IL-27 secretion. The mechanisms of endosomal TLR activation in the context of parasite replication is an important question to be addressed in the future.
More interestingly, we observed that TLR recognition of L. infantum does not induce direct IL-27 production; instead, type I IFN are intermediary cytokines involved in this response. Our results demonstrated that endosomal TLR3 and TLR9 are involved in IFN-␤ production. Moreover, type I IFN production is upstream of IL-27 production once IFN-␤ blockade with monoclonal antibodies reduces IL-27 levels. The signaling pathways involved in type I IFN-dependent IL-27 production are dependent on IFNAR and subsequent IRF1 activation to induce IL-27 production after L. infantum infection. These results are in accordance with TLR4-dependent production of IL-27, which also relies on the type I IFN intermediary response (33) . In the context of TLR activation, classical protective cytokines, such as IL-12, TNF, and IFN-␤, tend to be secreted at early time points in order to allow for adaptive response. However, the production of regulatory cytokines occurs at delayed time points in order to regulate the responses triggered by infection. Our results are in accordance with this scenario, once IL-27 is produced after the earlier secretion of type-1 IFN.
Altogether, our results demonstrated that L. infantum infection induces IL-27 production in a sequential pathway that involves the engagement of TLR3 and TLR9, production of type I IFN, and activation of IRF1 in macrophages. Secretion of IL-27 is important to drive the Th1 response but also plays a negative regulatory role in the production of IL-17, which impacts the host response by the reduction of neutrophil recruitment to the target organs (see Fig. S3 in the supplemental material). Thus, inhibition or blockade of IL-27 release could be an interesting target for the design of future interventions in the context of visceral leishmaniasis.
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